The impact of surgical training on early and long-term outcomes after isolated aortic valve surgery.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
27 Dec 2021
Historique:
received: 06 01 2021
revised: 13 05 2021
accepted: 09 06 2021
pubmed: 7 8 2021
medline: 6 4 2022
entrez: 6 8 2021
Statut: ppublish

Résumé

Patients presenting with more comorbidities, requiring more complex cardiac surgical procedures and an increase in public scrutiny are impacting on training programme because of the perceived risk of worse outcomes. Hence, we aimed to provide evidence that trainees as the first operator can achieve comparable results to consultants when performing isolated surgical aortic valve replacement. From 1996 to 2017, 2919 patients underwent surgical aortic valve replacement at the Bristol Heart Institute, operated on by either a consultant (n = 2220) or a trainee (n = 870) as the first operator. Propensity score matching was used to adjust for imbalance in the baseline characteristics of the 2 groups. Over a 21-year period, the proportion of trainee cases dropped from 41.5% to 25.9%. No differences in the rates and risk of in-hospital mortality, new cerebrovascular accidents, re-exploration for bleeding, deep sternal wound infection and length of stay were found between patients operated on in the 2 groups. Also, there was a comparable risk of late death between the 2 groups (HR 0.88; 95% CI 0.73-1.06; P = 0.27) and this was present regardless of trainees career level and patients surgical risk based on the EuroSCORE. Finally, we showed an increase in patients risk profile in the latest year but, this was not associated with the worst outcomes when trainees performed the operation. Surgical aortic valve replacement is a safe and reproducible technique and regardless of the patient's risk profile, and no differences in the outcomes between trainees and consultant cases were found.

Identifiants

pubmed: 34355735
pii: 6342837
doi: 10.1093/ejcts/ezab328
pmc: PMC8715849
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-186

Subventions

Organisme : British Heart Foundation
ID : CH/17/1/32804
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/33/31394
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1992027/7163
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

Ann Thorac Surg. 2011 Jan;91(1):49-55; discussion 55-6
pubmed: 21172485
Cardiol J. 2014;21(2):183-90
pubmed: 23799562
N Engl J Med. 1995 May 4;332(18):1229-32
pubmed: 7700321
Ann Thorac Surg. 2019 Jul;108(1):262-267
pubmed: 30880141
J Thorac Cardiovasc Surg. 2016 Jun;151(6):1508-15
pubmed: 26874603
Heart Lung Circ. 2018 Apr;27(4):420-426
pubmed: 29103675
Thorac Cardiovasc Surg. 2021 Jan;69(1):13-18
pubmed: 31770776
BMJ. 2004 Aug 21;329(7463):450-4
pubmed: 15321906
Interact Cardiovasc Thorac Surg. 2020 Dec 7;31(6):796-802
pubmed: 33150396
J Am Coll Cardiol. 1999 Sep;34(3):618-20
pubmed: 10483939
Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13
pubmed: 10456395
Ann Thorac Surg. 2020 Oct;110(4):1404-1411
pubmed: 32165177
Int J Surg. 2015 Jan;13:211-216
pubmed: 25498494

Auteurs

Arnaldo Dimagli (A)

Bristol Heart Institute, University of Bristol, Bristol, UK.

Shubhra Sinha (S)

Bristol Heart Institute, University of Bristol, Bristol, UK.

Umberto Benedetto (U)

Bristol Heart Institute, University of Bristol, Bristol, UK.

Massimo Caputo (M)

Bristol Heart Institute, University of Bristol, Bristol, UK.

Gianni D Angelini (GD)

Bristol Heart Institute, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH